BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Onyx Scientific Limited Strengthens Commercial Team


5/25/2012 11:23:54 AM

May 25, 2012 -- CHEMISTRY and manufacturing specialist Onyx Scientific has bolstered its business development team with the appointment of an experienced new director.

Brian Jolly joins the contract manufacturing organisation’s (CMO) UK team as Director of European Business Development and will be responsible for overseeing the company’s sales effort across Europe.

PhD qualified, Brian brings a wealth of experience to the company having spent over 25 years in a range of technical and commercial roles in specialty chemicals and the wider chemical industry.

Operating from MHRA and FDA licensed sites in UK and India, Onyx Scientific supports pharmaceutical and emerging biotech from medicinal chemistry and preclinical through Phase I-III, scaling-up to large scale commercial API production.

Denise Bowser, commercial director head at Onyx Scientific, said: “We are delighted to have Brian on board as he has a huge amount of commercial experience that will no doubt benefit the company’s continued growth.

“Although we have clients across the world, the European market remains a key one. It is therefore essential for us to have this level of expertise on the ground to service clients and potential customers.”

The CMO recently launched a new website (www.onyxipca.com) to reflect the company’s expanded service offering following its acquisition by Ipca Laboratories last year. Its team in Sunderland, UK, has dovetailed its chemistry services with the scale-up and manufacturing services offered by Ipca in India.

New appointment Brian said: “The thing that attracted me to Onyx Scientific was the company’s ambition for growth. It is a dynamic business with a fantastic reputation for expertise and competence for reliably delivering on its commitments to customers.

“It’s a fantastic new challenge for me and I am convinced this business has a solid foundation on which it can now grow and be recognised as a key player in the global contract manufacturing marketplace.”

Working as a preferred partner of many of the world’s top pharma firms, its UK-based labs deal with complex chemistry and deliver early stage programs involving custom synthesis, lead optimisation, process development, solid-state chemistry and GMP API synthesis. It is then able to scale-up, internally tech transfer and provide increased efficiency for clients from its commercial sites in India.

For more information about Onyx Scientific – visit www.onyxipca.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->